38 completed, 8 recruiting, 8 unknown, 4 not yet recruiting. 20 Not applicable, 14 Phase 3, 10 Phase 2, 8 Phase 4, 5 Phase 1.
Follow Fumigant 93: new trials by email Literature Review of Fumigant 93 trials Research Report on Fumigant 93
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled Trial Esketamine combined with dexmedetomidine, Dexmedetomidine - Dexmedetomidine, Ketamine | Phase 4 | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 356 | 2026-09-28 | 2026-09-03 |
| Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level Daratumumab, Lenalidomide, Dexamethasone - Multiple Myeloma (MM), Plasma Cell Leukemia (PCL) | Phase 3 | Recruiting | University of Leeds | 1226 | 2026-07-01 | 2026-07-15 |
| A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003 Pomalidomide Capsules, Bortezomib for Injection, Daratumumab Injection (Subcutaneous Injection) - Relapsed or Refractory Multiple Myeloma | Phase 3 | Recruiting | Innovent Biologics (Suzhou) Co. Ltd. | 255 | 2026-06-11 | 2026-09-17 |
| Effects of Staged Adapted Inclusions in Infant Cereals on Oral-motors Patterns of 6-24 Month-old Children A, B, C - Healthy, Infant and Young Child Feeding | Not applicable | Recruiting | Société des Produits Nestlé (SPN) | 153 | 2025-11-05 | 2026-01-06 |
| Evaluation of Oral Corticosteroid Therapy in Idiopathic Sudden Unilateral Hearing Loss. prednisone - oral corticosteroid 1mg/kg/D for 1 week, Placebo - Sudden Sensorineural Hearing Loss | Phase 3 | Not yet recruiting | Centre Hospitalier Universitaire de Besancon | 430 | 2025-11-01 | 2025-07-24 |
| A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets JDB0131 100mg, JDB0131 200mg, Delamanid (D) - Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis | Phase 2 | Recruiting | WestVac Biopharma Co., Ltd. | 60 | 2025-09-19 | 2026-01-30 |
| A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis bedaquiline, Pretomanid (Pa), linezolid - Efficacy and Safety | Not applicable | Not yet recruiting | Wuhan Pulmonary Hospital | 200 | 2025-09-01 | 2025-08-17 |
| Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis Bedaquiline (B), Moxifloxacin, Pyrazinamide (PZA) - Tuberculosis, Pulmonary, Drug-Susceptible Pulmonary Tuberculosis | Phase 2 | Not yet recruiting | Shanghai Pulmonary Hospital, Shanghai, China | 45 | 2025-08-20 | 2025-08-19 |
| Off-script Diagnosis & Differential Diagnosis (D&D) Training and Residents' Stroke Knowledge Off-script diagnosis & differential diagnosis (D&D) training - Stroke, Acute, Educational Problems | Not applicable | Completed | Peking Union Medical College Hospital | 22 | 2025-06-20 | 2026-08-12 |
| Exploring Parameters of Driving Simulation in Relation to Drug Holidays in ADHD Patients "drug holidays" (D) - ADHD - Attention Deficit Disorder With Hyperactivity, Driving Simulator Performance | Not applicable | Recruiting | Stefan Lakämper | 26 | 2025-06-02 | 2025-06-05 |
| Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort bedaquiline, delamanid, linezolid - Drug-resistant Tuberculosis, Pulmonary Tuberculosis | Phase 3 | Active not recruiting | Huashan Hospital | 120 | 2024-11-27 | 2025-09-02 |
| The Effect of a Combined Aerobic and Resistance Exercise (CARE) Training Programme on Cardiometabolic Outcomes in Individuals With Chronic Spinal Cord Injury: A Randomised Controlled Trial Dietary energy restriction group (D), Dietary energy restriction and exercise group (D+E) - Spinal Cord Injury | Not applicable | Unknown | University of Bath | 21 | 2024-05-22 | 2024-03-06 |
| Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB Ganfeborole, BTZ-043, Bedaquiline (B) - Pulmonary Tuberculosis | Phase 2 | Recruiting | University College, London | 2500 | 2024-01-09 | 2026-10-15 |
| Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem, Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor - Biliary Atresia, Cholangitis | Not applicable | Recruiting | Children's Hospital of Fudan University | 356 | 2023-07-01 | 2026-05-15 |
| A Practice Change for Patients With Severe Chronic, Clinically Unexplained Gastrointestinal Symptoms a)standardised dietician supervised intervention, b) exercise intervention, c) internet delivered cognitive behavior therapy or d) nothing, a) consultant-led outpatient clinic or b) a integrated care clinic - Gastrointestinal Diseases, Irritable Bowel Syndrome | Not applicable | Unknown | The University of Queensland | 200 | 2023-05-01 | 2024-11-12 |
| A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia (D) DWC202206, (D) DWC202207, (P) DWC202206 - Hypertension, Hyperlipidemias | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 214 | 2023-02-23 | 2026-04-30 |
| Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery Droperidol Injection, Saline - Digestive System Disease, Urologic Diseases | Not applicable | Terminated | RenJi Hospital | 797 | 2022-11-21 | 2026-08-12 |
| SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease Selinexor, Bortezomib, Lenalidomide - Multiple Myeloma | Phase 2 | Completed | The First Affiliated Hospital with Nanjing Medical University | 29 | 2022-07-15 | 2026-09-02 |
| Assessment of the Efficacy of Vitamins A and D and γ-oryzanol-fortified Canola Oil in Adults With Type 2 Diabetes fortified canola oil with vitamins A and D and γ-oryzanol, Active comparator, Placebo - Diabetes | Not applicable | Unknown | National Nutrition and Food Technology Institute | 90 | 2021-12-01 | 2022-03-08 |
| Efficacy and Safety of Dexketoprofen/Vitamin B Vs Dexketoprofen for Post-traumatic Cervical Sprain Grade I-II Dexketoprofen/Vitamin B, Dexketoprofen - Acute Low Back Pain | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 174 | 2021-11-23 | 2024-11-13 |
Showing 20 of 61. Sign in to see all of them.
Attention Deficit Disorder with Hyperactivity (4) · Iron Deficiencies (3) · Multiple Myeloma (3) · Osteoporosis (3) · Tuberculosis, Pulmonary (3) · Anemia, Iron-Deficiency (2) · Behavior (2) · Body Weight (2) · COVID-19 (2) · Hearing Loss, Sudden (2) · Hypertension (2) · Obesity (2) · Overweight (2) · Acquired Immunodeficiency Syndrome (1) · Agnosia (1)
Shire (3) · Boehringer Ingelheim (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · National Nutrition and Food Technology Institute (2) · Organon and Co (2) · The First Affiliated Hospital with Nanjing Medical University (2) · Amicus Therapeutics (1) · Assiut University (1) · Augusta University (1) · Baylor College of Medicine (1) · BeyondSpring Pharmaceuticals Inc. (1) · Canterbury Christ Church University (1) · Centers for Disease Control and Prevention (1) · Centre Hospitalier Universitaire de Besancon (1) · Centre Hospitalier de Cayenne (1)
China (14) · United States (11) · Australia (3) · United Kingdom (3) · Egypt (2) · France (2) · Germany (2) · Greece (2) · Iran (2) · Botswana (1) · Canada (1) · French Guiana (1) · Israel (1) · Mexico (1) · Moldova (1)
Betsy Lozoff, MD (2) · Tirang R. Neyestani, PhD (2) · Aboud Aljabari (1) · Adelfia Urenda Quezada, M.D (1) · Angelo Tremblay, PhD (1) · Carl E. Allen, MD, PhD (1) · Charlotte Pawlyn (1) · Clara Strauss, PhD (1) · Diab Hetta, MD (1) · Diansan Su, MD,PHD (1) · Donglian Cai, Master (1) · Eldar Carmel, MD (1)
PMID 20861587, PMID 27836288, PMID 19012813, PMID 19026251, PMID 19111318, PMID 19263591, PMID 21824454, PMID 22172095, PMID 23052695, PMID 23101946, PMID 23297844, PMID 24494204, PMID 24719139, PMID 24890347, PMID 25932839, PMID 26791556, PMID 29357902, PMID 31228031, PMID 35315690, PMID 35578345, PMID 35732751, PMID 36346044, PMID 36808186, PMID 37774185, PMID 37817285, PMID 37971692, PMID 38768617, PMID 38842764, PMID 39265599, PMID 41564431
2018 (1), P01HD039386 (1), R01HD052069 (1), T32AG023480 (1)